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Abstract 
Because of its many connections to other cell systems, the nuclear envelope is 
essentially impossible to purify to homogeneity.  To circumvent these problems, we 
developed a subtractive proteomics approach in which the fraction of interest and a 
fraction known to contaminate the fraction of interest are separately analyzed and 
proteins identified in both fractions are subtracted from the dataset.  This requires that 
the contaminating fraction can be purified to homogeneity. In this case, microsomal 
membranes are used to represent endoplasmic reticulum contamination, allowing the 
identification of transmembrane proteins specific to the nuclear envelope.  To 
circumvent problems commonly associated with analyzing membrane proteins, the 
Multi-dimensional Protein Identification Technology (MudPIT) proteomics 
methodology is employed.  
 
 
Key Words: Multi-dimensional Protein Identification Technology (MudPIT); liquid 
chromatography; tandem mass spectrometry; nuclear envelope; microsomal 
membranes; transmembrane proteins; inner nuclear membrane; nuclear lamina. 
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1. Introduction 
The nuclear envelope (NE) is comprised of a double membrane, its integral proteins, 
and the intermediate filament lamin polymer that underlies the membrane and binds 
several of its integral proteins.  While the inner nuclear membrane is clearly a 
subdomain of the nucleus, the outer nuclear membrane is both the outermost layer of 
the nucleus and a subdomain of the endoplasmic reticulum with which it is 
continuous.  As a result, the nuclear envelope is highly complexed with both 
cytoplasmic membranes and filament systems as well as chromatin (1-3).  These 
many interconnections render biochemical isolation of pure nuclear envelopes 
effectively impossible.  To circumvent this, we developed a subtractive proteomics 
approach (4).  Two fractions are separately analyzed: 1) a nuclear envelope-enriched 
fraction and 2) a fraction known to contaminate nuclear envelopes, but which can be 
purified completely clean from nuclei.  In this case microsomal membranes (MMs) 
were chosen as the contaminating fraction because they can be cleanly separated from 
intact nuclei at an early stage in the preparation (5).  To purify nuclear envelopes, 
nuclei are first isolated taking advantage of their mass and density (6), though many 
other cytoplasmic membranes and filament systems co-purify.  A large percentage of 
the contaminating membranes are removed by floating them on sucrose cushions that 
are penetrated by the dense nuclei.  Finally, the nucleoplasmic contents are removed 
by swelling nuclei, digesting chromatin, and washing away released chromatin again 
by pelleting the larger / heavier nuclear envelopes through sucrose (7, 8).  Microsomal 
membranes are purified by breaking the plasma membrane and vesiculating ER with 
dounce homogenization, removing nuclei and mitochondria by pelleting, and floating 
microsomal membranes on dense sucrose (5, 9, 10).  Due to the complexity of the 
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nuclear envelope, subsequent extraction steps may be employed depending on the 
goals of a particular study; however, it should be noted that all additional extractions 
carry with them the possible loss of true NE proteins.  Some subsequent purification 
procedures are based on the biochemical properties of the nuclear lamin polymer, 
which, together with associated transmembrane proteins, remains insoluble in the 
presence of the relatively high concentrations of salt and detergent used here (for 
review on lamin properties see (11)).  Other procedures rely on the solubility 
properties of membrane proteins and here, we describe alkali extraction to enrich for 
transmembrane proteins. 
 Multi-dimensional Protein Identification Technology (MudPIT) (12-14) was 
used to circumvent several inherent difficulties of working with membrane proteins. 
In shotgun proteomics, a complex protein mixture is digested into an even more 
complex peptide mixture.  This step may seem counter-intuitive but in actuality, 
peptides’ physicochemical properties are more homogenous than proteins’.  In 
particular, peptides can readily be separated by simple reverse phase chromatography 
techniques and their molecular weights are ideal to be analyzed by mass spectrometry.  
In addition, with the advent of tandem mass spectrometry, amino acid sequences can 
be deduced from peptide fragmentation patterns using software such as SEQUEST 
(15).  SEQUEST peptide level information is reassembled into protein lists using 
software such as DTASelect (16), while multiple protein lists are compared using 
software such as CONTRAST (16).  Proteins appearing in both NE and MMs 
fractions are subtracted from the dataset, leaving an in silico “purified” nuclear 
envelope-specific dataset (“subtractive proteomics”).  This NE-specific list of proteins 
can then be queried for the presence of transmembrane proteins.  All 13 previously 
known NE integral proteins (NETs) were readily identified, as well as all known 
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components of the nuclear pore complex. An additional 67 hypothetical 
transmembrane proteins were identified.  All eight of these novel putative NETs 
originally tested targeted to the NE (4), while subsequent characterizations have thus 
far confirmed the localization of nearly two dozen more NETs (17, 18, W. E. Powell, 
V. Lazou, D. Kavanagh, P. Malik, N. Korfali, and E. Schirmer, unpublished results). 
 
2. Materials 
2.1. Preparation of Tissue (Rodent Livers) 
2.1.1. Animals 
1. Volumes in the protocol are given based on grams of liver or OD of nuclei.  To 
estimate how many animals to use: ~5 g of liver can be obtained from one rat and 
~1.25 g of liver can be obtained from one mouse.  We generally produce 1,000 to 
2,000 OD of nuclei (1 OD = 3,000,000 nuclei) from the livers of 10 rats (see Note 1).  
2. 6-8 week old rats (e.g. Sprague-Dawly or equivalent) or mice (e.g. CB6F1/J or 
equivalent) (see Note 2).  
2.1.2. Hardware 
1. Guillotine or equivalent local method for euthanizing animals. 
2. Dissection scissors, scalpel, and forceps/ tweezers. 
3. Two beakers on ice, one with 200 mL of double distilled H20 and the other with 
200 mL of 0.25 M SHKM buffer (see Note 3).  
4. Appropriate materials for covering surfaces during procedure and for cleaning and 
waste disposal. 
2.1.3. Solutions 
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1. 0.25 M SHKM: 50 mM HEPES-KOH, pH 7.4, 25 mM KCl, 5 mM MgCl2, 250 
mM sucrose, and freshly added 2 mM DTT (dithiothreitol) and 1 mM PMSF 
(phenylmethylsulfonyl fluoride; from a 100 mM solution in ethanol) (see Note 4).  
 
2.2. Preparation of Nuclear Envelopes 
2.2.1. Hardware 
1. Potter-Elvehjem homogenizer with a motor-driven Teflon pestle providing 0.1 to 
0.15 mm clearance and the drive motor capable of 1500 rotations per minute (e.g. 
Potter S Homogenizer catalogue numbers 853 3032 (motor), 854 2600 (60-mL 
homogenizer cylinder), and 854 3003 (Plunger made of PFTE) from Sartorius or 
equivalent). 
2. Loose fitting (Wheaton type B pestle) glass dounce homogenizer with clearance of 
between ~0.1 and 0.15 mm. 
3. Swinging-bucket rotor with a tube capacity of at least 200 mL if processing 10 rats 
(e.g. Beckman Coulter SW28 rotor with Beckman Coulter 344058 Ultra-Clear 25 x 
89 mm centrifuge tubes). 
4. Local standard light microscope, glass slides, and coverslips. 
5. Assorted beakers, 2 funnels, and several spatulas. 
6. Sterile cheesecloth (see Note 5). 
7. Large bore luer lock stainless steel needles (e.g. 14 gauge) of greater length than 
centrifuge tubes and glass luer lock syringes.  
2.2.2. Solutions 
Solution names include the initials for the primary components: S for sucrose, H for 
HEPES-KOH, K for KCl, and M for MgCl2 (see Note 6). 
1. DNase (e.g. Sigma DNase I D4527) resuspended at 10 U/ µL in H2O. 
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2. RNase (e.g. Sigma RNase A R4875) resuspended in H2O at 10 mg/ mL and boiled 
for 20 min. 
3. Protease inhibitors (see Note 7): all solutions require freshly added 1 mM PMSF, 1 
µg/ mL aprotinin (from a 1 mg/ mL stock in H2O), 1 µM pepstatin A [from a 1 mM 
stock in DMSO (dimethyl sulfoxide)] and 10 µM leupeptin hemisulfate (from a 10 
mM stock in H2O) (see Note 8). 
4. 0.25 M SHKM: 50 mM HEPES-KOH, pH 7.4, 25 mM KCl, 5 mM MgCl2, 250 
mM sucrose, and freshly added 2 mM DTT (dithiothreitol; from a 1 M solution in 
H2O) and protease inhibitors.  This is the same solution used to wash the freshly 
isolated livers, except that additional protease inhibitors are added to the fresh buffer 
in which homogenization occurs. 
5. 2.3 M SHKM: 2.3 M Sucrose, 50 mM HEPES-KOH, pH 7.4, 25 mM KCl, 5 mM 
MgCl2, and freshly added 2 mM DTT (see Note 9). 
6. 30% SHKM: 0.9M Sucrose, 50 mM HEPES-KOH, pH 7.4, 25 mM KCl, 5 mM 
MgCl2, and freshly added 2 mM DTT and protease inhibitors (see Note 10). 
7. 30% SHM buffer: 0.9 M sucrose, 10 mM HEPES-KOH, pH 7.4, 5 mM MgCl2, and 
freshly added 2 mM DTT and protease inhibitors. 
8. 10% SHM buffer: 0.3 M sucrose, 10 mM HEPES-KOH, pH 7.4, 5 mM MgCl2, and 
freshly added 2 mM DTT and protease inhibitors. 
 
2.3. Preparation of Microsomal Membranes 
2.3.1. Hardware 
1. The same hardware is required as for Preparation of Nuclear Envelopes. 
2. A Ti45 fixed angle rotor or equivalent that can provide 150,000 g and matching 
tubes. 
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2.3.2. Solutions 
The same sucrose solutions used for Preparation of Nuclear Envelope can be used in 
preparing microsomes.  In particular the 2.3 M SHKM, 0.25 M SHKM, and a mixture 
of the two to 1.9 M sucrose will be required. 
 
2.4. Extraction of Fractions 
2.4.1. Hardware 
1. TLA100.3 rotor for table-top ultracentrifuge or equivalent and corresponding tubes 
(e.g. Beckman-Coulter 343778 polycarbonate 11 x 34 mm tubes). 
2.4.2. Solutions 
1. Salt/ detergent extraction: Octyl ß-D-glucopyranoside (also called n-Octyl 
glucoside; Sigma O9882) resuspended at 1% (w/v) in a solution containing 25 mM 
HEPES-KOH, pH 7.5, 400 mM NaCl. 
2. Alkaline extraction: 0.1 N NaOH, 1 mM DTT. 
 
2.5. Determining the Purity/ Quality of Fractions 
1. Standard labware for Western blotting and antibodies to lamins, characterized 
integral nuclear envelope and endoplasmic reticulum proteins. 
2. Electron microscope facility and glutaraldehyde for fixation. 
 
2.6. Preparation and Digestion of Proteins for MudPIT 
2.6.1. Hardware 
1. pH indicator strips, 7.5 to 14 (EMD Chemicals, Part # EM-9587-3; 
http://www.emdchemicals.com/). 
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2. Eppendorf Thermomixer and Thermomixer block for 1.5-mL tubes (Eppendorf, Part 
# 5355 000.011; http://www.eppendorf.com/). 
2.6.2. Solutions 
1. Ammonium bicarbonate (Sigma-Aldrich, Part # A6141; http://www.sigma-
aldrich.com), as a 1 M solution in double distilled H2O, pH adjusted to 8.5, stored at 
4oC. 
2. Urea, solid (Sigma-Aldrich, Part # U 1250). 
3. 90% formic acid (J.T. Baker, Part # JT0129-1; http://www.jtbaker.com). 
4. Cyanogen bromide (Sigma-Aldrich, Part # 48,143-2). 
5. Ammonium hydroxide solution, NH4OH (Sigma-Aldrich, Part # A6899, in H2O at 
0.9 g/mL density). 
6. Tris(2-Carboxylethyl)-phosphine hydrochloride, TCEP (Pierce, Part # 20490; 
http://www.piercenet.com/), as a 1 M stock in HPLC grade H2O, stored at -20oC. 
7. Iodoacetamide, IAM (Sigma-Aldrich, Part # I 1149), made fresh weekly as a 500 
mM stock in double distilled H2O, and stored at -20 oC. 
8. Endoproteinase LysC, sequencing grade (Roche Applied Science, Part # 
11047825001; http://www.roche-applied-science.com/), as a 1 µg/µL stock in double 
distilled H2O, stored at -20oC. 
9. Calcium chloride (EMD Chemicals, Part # EM-3000), as a 500 mM stock in double 
distilled H2O, stored at room temperature. 
10. Poroszyme bulk immobilized trypsin, bulk media (Applied Biosystems, Part # 2-
3127-00; http://www.appliedbiosystems.com/), stored at -20oC.   
 
 
2.7. Packing and Loading of Microcapillary Column  
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2.7.1. Hardware 
1. SPEC-PLUS PTC18 cartridges (Varian / Ansys Technologies Inc., Part # 572-03;  
http://www.varianinc.com/) 
2. 1-mL syringes (Becton, Dickinson and Co, Part # BD309602; http://www.bd.com). 
3. SpeedVac concentrator (Thermo Electron, Part # SPD111V; http:/www.thermo.com/). 
4. Micropipette laser-based puller (Sutter Instrument Co, Part # P-2000; 
http://www.sutter.com/). 
5. Polyimide-coated fused silica capillary, 100 µm i.d. x 365 µm o.d. (Polymicro 
Technologies, Part # TSP 100375; http://www.polymicro.com/). 
6. Column scribe (Chromatography Research Supplies, Part # 205312; 
http://www.chromres.com/crs/). 
7. Helium pressure cell (custom-made, MTA for blueprints available by request from 
John Yates, Scripps Research Institute, La Jolla, CA; or Brechbuehler, Inc., Part # 1 
100 110; http://www.brechbuehler.com/). 
2.7.2. Solutions 
1. HPLC grade methanol (EMD Chemicals, Part # EM-MX0488-6). 
2. HPLC grade acetonitrile (EMD Chemicals, Part # EM-AX0142-6). 
3. Glacial acetic acid (Sigma-Aldrich, Part# A 6283). 
4. 90% formic acid (J.T. Baker, Part # JT0129-1). 
5. Ammonium acetate (J.T. Baker, Part # JT0599-8). 
6. 5-µm Polaris C18A reversed phase column (Varian/Metachem Technologies, Part # 
2000-250X046; http://www.varianinc.com/) (see Note 11).  
7. 5-µm Partisphere strong cation exchange column (Whatman, Part # WC4621-1507; 
http://www.whatman.com/) (see Note 11). 
8. Buffer A: acetonitrile/formic acid/double distilled H2O, 5/0.1/95, v/v. 
 11
 
2.8. Liquid Chromatography in-line with Tandem Mass Spectrometry 
2.8.1. Hardware 
1. Agilent 1100 series G1379A degasser, G1311A quaternary pump, and G1323B 
controller (Agilent Technologies; http://we.home.agilent.com/). 
2. LCQ DECA tandem mass spectrometer (Thermo Electron). 
3. Nano electrospray stage (custom-made, MTA for blueprints available by request 
from John Yates, Scripps Research Institute, La Jolla, CA; or Thermo Electron 
Nanospray II ion source; or Brechbuehler, Inc., Part # 1 2000 1000). 
4. MicroTight Cross (UpChurch Scientific, Part # P-777; http://www.upchurch.com/). 
5. Micro Ferrule for 360 µm o.d. tubing (UpChurch Scientific, Part # F-152). 
6. Polyimide coated fused silica, 50 µm i.d. x 365 µm o.d. (Polymicro Technologies, 
http://www.polymicro.com/; Part # TSP 050375). 
7. Gold wire 0.025” diameter (Scientific Instrument Services, http://www.sisweb.com/; 
Part # W352). 
2.8.2. Solutions 
1. Buffer A: acetonitrile/formic acid/double distilled H2O, 5/0.1/95, v/v. 
2. Buffer B: acetonitrile/formic acid/double distilled H2O, 80/0.1/20, v/v. 
3. Buffer C: 500 mM ammonium acetate in buffer A, filtered. 
 
2.9. Data Analysis 
2.9.1. Searching MS/MS dataset 
SEQUEST™ (15) (Thermo Electron and John Yates, Scripps Research Institute, La 
Jolla, CA) and/or PEP_PROBE (19). 
2.9.2. Assembling and comparing protein lists 
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DTASelect / CONTRAST (16) (available by request from John Yates, Scripps 
Research Institute, La Jolla, CA).  
2.9.3. Appending transmembrane domain predictions 
TMpred (20) (http://www.ch.embnet.org/software/TMPRED_form.html). 
 
3. Methods 
The first step in NE enrichment is the isolation of nuclei.  Critical to this step and all 
subsequent steps is the fact that nuclei from different tissues have distinct densities; 
thus the concentration of sucrose in buffers may need to be altered or centrifugation 
steps lengthened if nuclear envelopes are to be isolated from tissues other than liver 
(see Note 12).  
3.1. Preparation of Tissue (Rodent Livers) 
Most of the nuclear envelope preparation procedure can be efficiently performed with 
one individual; however euthanizing and dissecting the animals should be done 
quickly and it is very helpful to have assistance at this point. 
1. Overnight-fast the animals the night before procedure (See Note 13). 
2. Euthanize rats or mice according to local animal protocols. 
3. Immediately pull up on the ventral skin to isolate from the abdominal cavity.  Make 
an incision anterior to posterior and two perpendicular incisions above the thoracic 
vertebrae and below the abdomen.  Peel the skin back to access the liver. 
4. Remove the liver with a scalpel being extremely careful to avoid the yellowish tube 
directly behind (See Note 14). 
5. While clasped in the forceps rinse fresh livers quickly in the beaker on ice 
containing H2O on ice and then immediately place in the pre-weighed beaker on ice 
containing 0.25 M SHKM buffer with freshly added PMSF. 
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6. Return to the laboratory with livers as soon as local animal protocols have been 
satisfied.  If possible, have two people working at this point so that one can begin 
processing the material while the other deals with disposal and clean-up. 
7. Weigh livers to determine the volume of buffer to be added for homogenization. 
 
3.2. Preparation of Nuclear Envelopes 
1. Pour off the buffer and resuspend the livers in fresh, ice-cold 0.25 M SHKM with 
freshly added protease inhibitors (see Note 15) at 2 mL of buffer for every gram of 
liver, e.g. 50 g of livers should be resuspended in 100 mL of buffer (see Note 16). 
2. Use scissors to chop livers into small pieces in the beaker with buffer. 
3. Pour into a 55-mL Potter-Elvehjem homogenizer and homogenize at 1,500 rpm in 
the cold, bringing the pestle to the bottom three times (see Note 17). 
4. Rinse the homogenizer with buffer and add to the homogenate. 
5. In a cold room, fold cheesecloth over four times and lay in funnel.  Pour ~40 mL of 
crude homogenate through the cheesecloth (see Note 18).  
6. As the flow slows, fold the cheesecloth over and roll a sterile pipette along the 
outside from top to bottom to squeeze the fluid out.  A wash with buffer poured into 
the central cavity formed by the cheesecloth may increase yield slightly.   
7. Remove to round-bottom centrifuge tubes (see Note 19) and underlay with a 
cushion of 30% SHKM using a 14 gauge needle and syringe.  Pellet nuclei at 1,000 g 
in a swinging bucket rotor (e.g. 2,000 rpm in a Beckman Coulter J6MI floor model 
centrifuge) for 10 min at 4°C. 
8. Remove the supernatant carefully as the pellets are very soft.  Keep this supernatant 
if microsomal membranes are going to be prepared at the same time from the same 
tissue as they will be in this fraction.  
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9. Resuspend pellets in 2.3 M SHKM and homogenize in Potter-Elvehjem 
homogenizer with three more strokes of the pestle at 1,500 rpm.  Rinse with the same 
buffer, accrue, and dilute with 0.25 M SHKM to a concentration of 1.9 M sucrose. 
10. Aliquot by 25 mL into each SW28 ultracentrifuge tube and underlay with 5 mL of 
2.3 M SHKM using a 14 gauge needle in a luer lock syringe (see Note 20). 
11. Balance the tubes from top and spin in SW28 rotor for 60 min at 82,000 g (25,000 
rpm). 
12. Move to cold room and scrape the red layer at the top off with a spatula, then pour 
off the rest of the supernatant by rapid inversion.  Keep the tubes upside down in the 
cold for 10 min to drain them.  Then gently wipe out the inside walls of the tubes with 
a folded kimwipe (or equivalent towel), being very careful not to touch the pellet. 
13. Insert a clean dry spatula without touching the walls of the tube and scrape out the 
nuclear pellet.  It is important that the spatula be dry so that the pellet will cling to it.  
Remove, again avoiding touching the walls of the tube, and resuspend the pellet in 
0.25 M SHKM with freshly added 2 mM DTT and protease inhibitors (see Note 21).  
14. Resuspend the pellet using a loose (Wheaton B-type pestle, ~0.1- 0.15 mm 
clearance) dounce homogenizer until all aggregates are broken.  Wash the 
homogenizer with the same buffer and remove to round-bottom centrifuge tubes.  
Underlay with 5 mL of 30% SHKM with freshly added 2 mM DTT and protease 
inhibitors as in step 6.  Pellet nuclei by centrifugation at 1,000 g for 10 min. Decant 
by inversion as the pellet should be compact (see Note 22).  
15. Resuspend in 0.25 M SHKM, dounce again, and take a small aliquot for counting 
nuclei in a hemacytometer and for step 17.  Then repeat pelleting as in step 14. 
16. During centrifugation count nuclei.  The number of nuclei in the squares on the 
field should be multiplied by 104 (unless a different correction factor applies to your 
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hemocytometer) and by the total volume (in mL) in which cells were resuspended for 
centrifugation in step 15.  This number should be divided by 3 x 106, which is the 
number of nuclei in an OD.  The formula is: 
 
ODtotal = [# nuclei on grid x 104 (nuclei/ ml) x # ml]/ [3 x 106 (nuclei/ OD)] 
 
17. Resuspend in 10% SHM with freshly added 2 mM DTT and protease inhibitors at 
20 OD/ mL.  Take an aliquot to compare nuclei to the aliquot saved in step 15.  The 
cells should be observed to swell in the hypotonic SHM buffer. 
18. Add 4 U/ mL DNase and 1 µg/ mL RNase and incubate at room temperature for 
20 min.  Observe digestion on the microscope in parallel.  The phase grey of the 
nuclei should diminish slightly (see Note 23).  
19. Underlay the solution with 30% SHM with freshly added DTT and protease 
inhibitors.  Spin 30 min at 6,000 g using a swinging bucket rotor (e.g. 5,000 rpm in a 
Beckman Coulter floor model J6MI centrifuge) (see Note 24). 
20. Carefully aspirate off the supernatant (do not decant by pouring) as the pellet will 
be very soft (see Note 25).  
21. Resuspend the pellet at 50 OD/ mL in 10% SHM.  Add 20 U/ mL DNase and 5 
µg/ mL RNase and incubate at room temperature, carefully following the digestion in 
an aliquot under the microscope.  When 90% of nuclei are no longer phase-grey, 
aliquot 4 mL of nuclear envelope solution (200 OD) each to centrifuge tubes (chosen 
for desired storage method) and spin at 6,000 g (5,000 rpm) for 30 min (no cushion). 
22. Carefully aspirate the supernatants and immediately flash-freeze the pellets in 
liquid nitrogen and store at -80°C. 
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3.3. Preparation of Microsomal Membranes 
1. The supernatant after pelleting of nuclei (step 7 in Preparation of Nuclear 
Envelopes) is supplemented with 0.5 mM EDTA to inhibit metalloproteases and 
subjected to a subsequent centrifugation at 10,000 g (11,500 rpm in a Ti45 Beckman 
Coulter ultracentrifuge rotor or 10,500 rpm in a JA25 Beckman Coulter centrifuge 
rotor) for 15 min to remove mitochondria (see Note 26).  
2. The post-mitochondrial supernatant is mixed with 5 volumes (e.g. 1 mL + 5 mL) of 
2.3 M SHKM containing 0.5 mM EDTA, 2 mM DTT, and protease inhibitors to 
achieve a final sucrose concentration of just under 2 M sucrose. 
3. Float the microsomal membranes by pouring 35 mL of the diluted membranes in 
each Ti45 tube and overlay with 9.5 mL of 1.9 M SHKM with 0.5 mM EDTA, 2 mM 
DTT, and protease inhibitors and overlay this with 3 mL of 0.25 M SHKM with 0.5 
mM EDTA, 2 mM DTT, and protease inhibitors.  Centrifuge at 57,000 g (27,000 rpm) 
in Ti45 rotor for 5 h (see Note 27).  
4. The microsomal membranes will be in the interphase beween the 1.9 M sucrose 
phase and have a yellow-brown appearance (at least in liver).  Above this band should 
be a clear phase on top of which will be a white flakey band.  Below the 1.9 M to 
lower phase transition the media should begin taking on a pink shade.  The yellow-
brown microsomal membrane band can be recovered by extraction with a syringe 
either through tube puncture from the side with a needle and or by inserting the needle 
through the upper phase (see Note 28). 
5. The membranes are diluted with 4 volumes of 0.25 M SHKM containing 0.5 mM 
EDTA, freshly added DTT and protease inhibitors and are pelleted at 152,000 g 
(44,000 rpm in a type 45 Ti, 48,000 rpm in a type 50 Ti, or 60,000 rpm in a TLA100.3 
rotor) for 75 min (see Note 29). 
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3.4. Extraction of Fractions 
1. Alkaline extraction. Resuspend 100 OD of nuclear envelope or microsomal 
membrane pellet on ice in 1 mL of 0.1 M NaOH.  Immediately move to TLA100.3 
ultracentrifuge tubes and pellet insoluble material at 104,000 g (35,000 rpm) for 35 
min (see Note 30). Rinse the packed pellet rapidly with double distilled H2O and 
either freeze at -80°C or directly process to digest for mass spectrometry. 
2. Extraction with salt and detergent.  Resuspend nuclear envelope pellet in salt/ 
detergent buffer and incubate on ice for 15 min, move to TLA100.3 ultracentrifuge 
tubes and pellet insoluble material at 104,000 g (35,000 rpm) for 35 min.  Rinse the 
packed pellet with double distilled H2O and either freeze at -80°C or directly process 
to digest for mass spectrometry. 
 
3.5. Determining the Purity/ Quality of Fractions 
1. Western blotting, estimating a protein concentration of ~3 µg/ OD, can be used to 
track the partitioning of known nuclear envelope or microsomal membrane proteins 
during cell fractionation (Figure 1) and in subsequent extraction of nuclear envelopes.  
We generally use antibodies to nuclear lamins, the inner nuclear membrane proteins 
LAP1 and LAP2 (available from Babco), and the endoplasmic reticulum marker RIC6 
(anti-ribophorin). 
2. Electron microscopy can also be used to determine the quality of nuclear envelopes 
and microsomal membranes.  For examples of clean preparations see (7). 
 
3.6. Preparation and Digestion of Proteins for MudPIT 
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Salt and detergent extracted NE proteins from mouse and rat livers (ca. 225 µg and 
375 µg proteins, respectively) are digested with endoproteinase Lys-C and Trypsin, 
while membrane pellets from NaOH-extracted mouse NEs and MMs are first 
solubilized in 90% formic acid and cyanogen bromide, before being further digested 
with endoproteinase Lys-C and trypsin.  
3.6.1. Salt and detergent extracted NEs 
1. Resuspend salt and detergent extracted NE pellets from mouse and rat livers in 200 
µL of 0.1 M ammonium bicarbonate, pH 8.5, 8 M urea.  
2. To reduce disulfide bonds, add 1 M TCEP to 5 mM final concentration and 
incubate at room temperature for 30 min. 
3. To carboxyamidomethylate free cysteines, add 500 mM IAM to 10 mM final 
concentration and incubate at room temperature for 30 min in the dark. 
4. Add Endoproteinase Lys-C (at 1 µg/µL) to a final substrate to enzyme ratio of 
100:1 (w/w) and incubate at 37°C overnight with shaking. 
5. Dilute sample to 2 M urea with 100 mM ammonium bicarbonate, pH 8.5. 
6. Add 1 M CaCl2 to a final concentration of 2 mM. 
7. Add 10 to 15 µL of trypsin beads at 37°C (approximate substrate to enzyme ratio of 
100:1) and incubate overnight with shaking. 
8. Spin samples at 15,000 rpm for 30 min. 
9. Pull off supernatants (discard bead pellets). 
3.6.2. NaOH extracted NEs and MMs 
1. Under a fume hood, resuspend the membrane pellets in 100 µL of 90% formic acid, 
500 mg/mL CNBr; mix well by pipetting and leave overnight in the dark. 
2. Add concentrated NH4OH drop by drop on ice. Check pH using pH indicator strips 
after every 100 µL of added NH4OH. The final pH should be around 8.5, and the final 
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volume should be around 500 µL, corresponding to a 3- to 5-fold dilution (see Note 
31). 
3. Add solid urea to 8 M. 
4. The next steps are as in 3.6.1. 2 through 9, with the exception that IAM is added to 
20 mM final concentration.  
 
3.7. Packing and Loading of Microcapillary Column  
After digestion, the peptide mixtures are usually in large final volumes. In particular, 
the CNBr/trypsin digestion, with its multiple dilution steps, can reach volumes of well 
over 1 mL, which would take a while to load onto traditional 100-µm columns. To 
concentrate and desalt the samples, we use an off-line solid phase extraction on these 
peptide digests, before loading them onto custom-made microcapillary columns. 
3.7.1. Solid Phase Extraction of Peptide Mixtures 
1. Wash a SPEC-PLUS PTC18 cartridge with 50 µL of MeOH (push the solution 
through using a 1-mL syringe). 
2. Wash the cartridge twice with 400 µL of 0.5% (v/v) acetic acid in water (after this 
step, do not allow the cartridge to dry). 
3. Load the peptide mixture. 
4. Wash the loaded cartridge four times with 400 µL of 0.5% acetic acid. 
5. Elute peptides off with 50 µL of acetonitrile/acetic acid/water, 90/0.5/9.5, v/v. 
6. Speed-vac the samples down to dryness. 
7. Add acetonitrile/acetic acid/water, 5/0.5/94.5, v/v to a final volume of 20 µL. 
8. Store at -80°C or load directly onto a 100 µm microcapillary column. 
3.7.2. Double-Phase Fused-Silica 100 µm Microcapillary Column 
1. Place about 40 cm of 100 µm i.d. x 365 µm o.d. fused silica into P-2000 laser puller 
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and use heating/pulling cycle settings (see Note 32) such as to pull the capillary to 
about a 5 µm opening. 
2. Make slurries of 5 µm Polaris C18 Reverse Phase and of 5 µm strong cation 
exchange SCX material, both at about 15 mg/mL in 500 µL of methanol (see Note 
33).  
3. Pack fused silica column with 9-10 cm of 5 µm Polaris C18 RP using the high 
pressure loading device (Figure 2A). Mark resin level in column with a marker (see 
Note 34).  
4. Pack with 4-5 cm of 5 µm strong cation exchange material (Figure 2B). 
5. Wash with methanol for at least 10 min. 
6. Equilibrate in Buffer A for at least 30 min. 
3.7.3. Off-Line Loading and Desalting 
1. Load the sample onto the microcapillary column by placing the sample-containing 
Eppendorf tube in the high pressure device (Figure 2C). 
2. Wash with Buffer A for at least 30 min using the high pressure device. 
 
3.8. Liquid Chromatography in-line with Tandem Mass Spectrometry 
3.8.1. Multidimensional Liquid Chromatography 
1. Install the loaded and washed two-phase microcapillary column on the 
nanoelectrospray stage. Connect the microcapillary column, quaternary HPLC pump, 
gold wire through which a 2.4 kV voltage is applied to the liquid phase, and overflow 
tubing using a MicroTight Cross (Figure 2D).  
2. Keep the HPLC flow rate constant at 0.1 mL/min throughout the chromatography. 
However, to achieve a slower flow rate at the tip of the column of about 200-300 
nL/min, split the flow using a waste line consisting of 50-µm fused silica capillary cut 
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to about 40 cm (i.e. back pressure of ~40 bar).  
3. Run a 12-step chromatography run (24 hours) on samples with the gradient 
parameters described in Figure 3. The chromatography is set up through and 
controlled by the XcaliburTM instrument software.  
 
3.8.2. Tandem Mass Spectrometry 
1. Using XcaliburTM, set up the collision energy at 35%.  
2. Implement an acquisition scheme such that a cycle of one full MS scan (from 400 
to 1600 m/z) followed by three MS/MS events on the top three most intense ions is 
repeated continuously throughout the chromatographic elution time. 
3. To allow less intense ions to be analyzed, enable dynamic exclusion for 5 min. 
4. Convert each RAW file (one per chromatographic step) into a DAT file using the 
XCalibur file converter function. 
 
3.9. Data Analysis 
3.9.1. Searching the MS/MS dataset 
1. To obtain the coordinates of the MS/MS spectra to be analyzed, convert each DAT 
file into a MS2 file using extract-ms (21) (Figure 4). 
2.  To remove spectra of poor quality and tentatively assign a charge state to precursor 
ions, apply the 2to3 software to MS2 files (22) . 
3. To match MS/MS spectra to peptides, use SEQUESTTM (15) or PEP_PROBE (19) 
(see Note 35) against a database containing human, mouse and rat protein sequences 
downloaded from NCBI (National Center for Biotechnology Information): this was 
106,360 sequences on April 24th, 2003, and was complemented with 172 sequences 
from usual contaminants (human keratins, IgGs, proteolytic enzymes). Set the 
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sequest.params file such as i) the peptide mass tolerance is 3, ii) no enzyme 
specificity is required, iii) parent ions are calculated with average masses, while 
fragment ions are modelled with monoisotopic masses, and iv) cysteine residues are 
considered fully carboxyamidomethylated and searched as bearing a static 
modification of +57 Da. 
3.9.2. Assembling and comparing protein lists 
1. To assemble and parse the peptide information contained in the SEQUEST output 
files, run DTASelect on SQT files (Figure 4).   
2. To compare the proteins detected in salt and detergent-extracted NE, NaOH-
extracted NE and NaOH-extracted MM samples, create a CONTRAST table (Figure 
4). The validity of peptide/spectrum matches is assessed primarily with the 
PEP_PROBE-defined confidence for a match to be non-random (at least 85%). In 
addition, spectra passing this filter have to match peptides that are at least 7-amino-
acid-long, with a normalized difference in cross-correlation scores (DeltCn) of at least 
0.08, and minimum cross-correlation scores (Xcorr) of 1.8 for singly-, 2.5 for doubly-
, and 3.5 for triply-charged precursors. Proteins identified by single unique peptides 
are allowed (see Note 36), while contaminants, human keratins and proteins that are 
subsets of others are removed from the final list.  
3. To create subset databases, in fasta format, containing only the proteins in the final 
list, use the “Database” utility of CONTRAST (add “Database” to the [Options] field 
of Contrast.params file). 
4. To generate tab-delimited text files linking proteins to peptides, using the “--DB” 
option in the [Criteria Sets] field of Contrast.params file (Figure 4). 
3.9.3. Appending transmembrane domain predictions 
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1. Predict the number of transmembrane segments using TMPred on a FASTA file 
containing the amino acid sequences for all detected proteins. Set a minimum score of 
1000 in one orientation and 1900 in both (see Note 37). 
2. Build a table linking proteins and number of predicted transmembrane domains. 
3.9.4. Generating a list of putative nuclear envelope transmembrane proteins. 
1. Consolidate protein lists and TM table into a relational database using MSAccess. 
2. Query for hypothetical proteins with transmembrane domains detected in either of 
the NE preparations but not the MM samples (Figure 4) (see Note 38). 
 
4. Notes 
1. As with most protocols there is an optimal middle-ground with too little or too 
much starting material resulting in lower yields.  In our hands, ten to twelve rats 
produce optimal yields without saturating the sucrose gradients in a Beckman-
Coulter SW28 rotor. 
2. This mouse strain was chosen to obtain more tissue per animal because it has 
much greater than average body weight (~35 g at 9 weeks).  When choosing a 
heavier strain it is important to check that the mice do not have diabetes-related 
problems as this could bias results, some NE diseases having associated diabetes 
defects.  The CB6F1/J strain is free of such defects. 
3. It is recommended to pre-weigh the beaker containing the SHKM buffer as it 
simplifies measuring the weights of the livers. 
4. This will also be needed in the Preparation of Nuclear Envelopes section, except 
that different and additional protease inhibitors should be added then.  The PMSF 
is added here because additional proteases (mostly serine) may be released onto 
the liver tissue during dissection. 
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5. Muslin will also do if not chemically treated: make certain to ask supplier. 
6. MgCl2 concentration in the original procedure was 5 mM throughout; however if 
nuclear envelopes are being prepared for viewing by electron microscopy, 
dropping the concentration through most of the procedure to 0.1 mM will yield 
better structure.  However, during DNase and RNase treatment it is important to 
increase the MgCl2 concentration back to 5 mM. 
7. The optimal protease inhibitors will vary according to the tissue being 
investigated; so it is important to investigate what proteases are present at high 
concentrations in the tissue of choice.  The choice for liver focuses on inhibiting 
serine, trypsin, cysteine, and aspartic proteases present in this tissue. 
8. If general protease cocktails are used, it is important to make certain that they do 
not contain EDTA as this is bad for nuclear envelope preparation. 
9. The solution can be prepared by adding 230 mL of an 85% (w/v) sucrose stock to 
12.5 mL of 1 M HEPES-KOH, pH 7.4, 6.25 mL of 1 M KCl, and 1 mL of 1 M 
MgCl2, and freshly added 2 mM DTT and protease inhibitors.  Other 
concentrations of sucrose can then be obtained by mixing the 2.3 M SHKM with 
the 0.25 M SHKM. 
10. The stock solution can be prepared by mixing 67 mL of 0.25 M SHKM to 33 mL 
of 2.3 M SHKM. 
11. Bulk material is not available. The resin is extracted by cutting the HPLC column 
in half with a hacksaw, then washed with methanol, dried, and stored as a powder. 
12. Chapters detailing modifications of the nuclear envelope protocol for human 
blood lymphocytes and rat muscle are being prepared for other volumes in the 
Methods in Molecular Biology series. 
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13. This has been experimentally shown to increase yields by 30-50% with this 
procedure and reduces the RNA/ DNA ratio (6). 
14. This tube is particularly rich in proteases, so it is important to avoid cutting it or 
mixing it with the isolated liver. 
15. As many protease inhibitors are short-lived, it is important to add them fresh to 
buffers shortly before use throughout the procedure 
16. One can avoid the weighing step and estimate 5 g per liver. 
17. This requires a reasonable amount of physical strength and one must take care to 
keep the homogenizer straight with the direction of the pestle or the homogenizer 
can break.  Also never stop the pestle rotation while it is inserted inside the 
homogenizer with liquid or this also can become stuck or break due to the vacuum 
produced during homogenization. 
18. There is an enormous amount of collagen in rat liver and this will clog the 
cheesecloth and reduce the yield if the cheesecloth is overloaded.  Therefore the 
homogenate from no more than 3 rats should be filtered through one four times-
folded cheesecloth.  Mice have much less collagen than rats and therefore roughly 
twice the amount of material can be used for the same amount of cheesecloth. 
19. We prefer these because the pellet tends to distribute widely, but conical tubes 
could also be used. 
20. Due to the high viscosity of the 2.3 M sucrose solution it takes several minutes for 
each tube if an 18 gauge needle is used.  In contrast, with the wide bore size of the 
14 gauge, this same procedure can be performed in 30 seconds.  It is important to 
use a luer lock syringe because the viscosity of the solution can produce high 
pressure on the connection. 
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21. It is critical to avoid touching the walls because they are rich with proteases that 
were associated with the floated membranes. 
22. This and step 13 are done to wash away some of the high amount of 
contaminating collagen prior to extraction of nucleoplasmic contents.  These 
washes are necessary to prevent saturation of sucrose cushions when chromatin is 
released, but are only necessary for liver preparations and other tissues that are 
particularly high in collagen. 
23. Do not be concerned if the nuclei do not become phase-lucent at this point as this 
first treatment might be viewed as generally loosening rather than fully digesting 
the chromatin and, moreover, the digestion will continue during centrifugation. 
24. It is very important to use a swinging bucket rotor when spinning through the 
sucrose cushion at this point in order to float any chromatin that is released away 
from the nuclear envelopes. 
25. The supernatant will appear cloudy, but this is mostly chromatin that has been 
ejected and should give a dark, worm-like appearance under the microscope quite 
distinct from nuclear envelopes. 
26. The pellet here may be larger than the nuclear pellet. 
27. The membranes can be floated using either a fixed angle rotor or using a swinging 
bucket rotor (e.g. SW28).  Better separation can be achieved if a second SW28 
rotor and ultracentrifuge is available when nuclear envelopes and microsomal 
membranes are being prepared simultaneously.  In this case, 20 mL of the diluted 
membranes are overlaid with 6 mL of the 1.9 M SHKM and this is overlaid with 
2.3 mL of the 0.25 M SHKM and centrifuged at 57,000 g (~21,000 rpm) for 4 h.   
28. Extracting the microsomal membranes by side puncture is only possible if SW28 
rotor and tubes are used, as the type 45 Ti rotor tubes are thick walled. 
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29. The type 45 Ti rotor tubes must be filled to close to the top or they can collapse.  
There should be an orange pellet in the corner of the tube.  Decant supernatant and 
freeze. 
30. It is critical to get this spinning immediately as loss of membrane proteins was 
observed by Western and membrane vesicles looked very fragmented by electron 
microscopy even after just 10 min sitting on ice prior to centrifugation (Tinglu 
Guan, personal communication).   
31. Because adding the base to the acidic sample causes “bubbling”, it is best to 
transfer the sample to a larger 15-mL conical tube in ice before neutralizing it, and 
then transfer it back to the smaller tube when the appropriate pH is reached. 
32. A typical four-step parameter setup for pulling approx 3 to 5-µm tips from a 100 
µm i.d. × 365 µm o.d. fused silica capillary is: [Heat = 290, Velocity = 40, and 
Delay = 200], [Heat = 280, Velocity = 30, and Delay = 200], [Heat = 270, 
Velocity = 25, and Delay = 200], [Heat = 260, Velocity = 20, and Delay = 200], 
with all other values set to zero. 
33. This concentration roughly corresponds to an amount of resin powder covering 
the tip of a small spatula, about 2-3 mm3. 
34. Using a black brackground behind the capillary being packed helps seeing the 
reverse phase and SCX resin levels inside the column. 
35. PEP_PROBE is a modified version of SEQUEST, which can calculate the 
confidence for a match to be non-random based on an hypergeometric probability 
model. Alternatively, False Discovery Rates (FDR) can be estimated by 
concatenating to the sequence database to be searched, randomized versions of 
each protein sequence (keeping the same amino acid composition and length). The 
theory is that for each spectrum matching a “shuffled” peptide (true negative) 
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there should be a false positive in the “normal” peptide dataset (23). Xcorr and 
DeltaCn values are then set such as to obtain peptide FDRs of less than 1%. 
36. Although a two-peptides per protein cut-off allows for higher confidence, single 
peptide identifications are reported in the final dataset because some well-
characterized NETs were detected by single peptides in previous studies, likely 
due to their lesser abundance. 
37. These score limitations are based on an average to match those of the previously 
characterized NE proteins. 
38. The selection criteria applied in this study (4) to discriminate true NET proteins 
from contaminating ER proteins is very conservative, since only proteins that 
were not found in MM fractions were considered for further analysis. However, 
differences in sequence coverage (percentage of a protein sequence covered by 
identified peptides) (24, 25) or spectral counts (number of spectra matching 
peptides from a protein) could be used as semi-quantitative parameters to 
determine whether a particular protein is “enriched” in a fraction of interest.  
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FIGURE LEGENDS 
Figure 1.   
 
Enrichment of rat liver NEs during the procedure.  Different fractions were kept 
during the NE purification and concentrated so that the same percentage of each 
fraction was loaded in gel sample wells.  Fractions were resolved by SDS-PAGE, 
transferred to PVDF membranes, and reacted with antibodies to lamin B1, a well 
characterized NE protein.  This NE marker was not notably lost during 
homogenization (compare “tissue” to “total homogenate”) and chromatin extraction 
steps (compare “nuclei” to “nuclear envelopes”).  Moreover, lamin B1 was largely 
absent from the three phases through which nuclei pelleted in the sucrose gradient 
step (“upper phase”, “interphase”, and “lower phase”). 
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Figure 2.  
 
Column Packing, Loading and Setup. A.  A  100 µm fused silica capillary with a 
pulled tip is inserted into a high pressure device and packed using Helium pressure 
with a slurry of Aqua C-18 RP in methanol. B. The column is then packed with SCX 
material in a slurry, then washed with Methanol and Buffer A. C.  The complex 
peptide mixture is pressure-loaded onto the column which is subsequently 
equilibrated in Buffer A.  D.  Loaded and washed column is installed in-line with a 
quaternary HPLC pump and a tandem mass spectrometer via a micro cross. 
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Figure 3.  
 
Gradient Profiles for a 12-step MudPIT Run. Buffer A, B and C varying 
concentrations are represented by the dark gray areas, the light gray areas, and the 
striped white bars, respectively. A representative baseline ion chromatograph is 
shown in the forefront (black peaks) for each step (from the analysis of the complex 
peptide mixture obtained from mouse NaOH-extracted NEs). Each chromatographic 
step lasts 112 minutes. The salt concentration is equal to 4, 10, 15, 20, 30, 40, 50, 60, 
80, and 100 % C in steps 1 through 10, respectively.  In steps 1 through 10, the salt 
bump starts after 3min and lasts 2 minutes, while it lasts 20 minutes in the last two 
chromatographic steps. In steps 1 through 10, a rapid increase from 0 to 15% Buffer B 
occurs between 5 and 10 minutes, followed by a slow ramp to 45% B over 97 
minutes. For steps 11 and 12, Buffer B concentration increases rapidly to 15% 
between 22 and 30 minutes, followed by a slow ramp to 55% B over 82 minutes.  
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Figure 4.  
 
Subtractive Proteomics Work Flow and Summary of Results. Protein and peptide 
mixtures are circled in light gray ovals, while processes are drawn within hexagons. 
Software are underlined in rectangles, while file types are italicized and in gray boxes. 
A total of 67 uncharacterized proteins with at least one predicted transmembrane 
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domain were found in at least one of the NEs preparations but not in the MMs runs. 
These are defined as putative nuclear envelope transmembrane proteins (NETs). 
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